Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

83 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Treatment with statins and peripheral neuropathy: results of 36-months a prospective clinical and neurophysiological follow-up.
Otruba P, Kanovsky P, Hlustik P. Otruba P, et al. Neuro Endocrinol Lett. 2011;32(5):688-90. Neuro Endocrinol Lett. 2011. PMID: 22167150 Clinical Trial.
Neurophysiological examination of lower-limb peripheral nerves demonstrated statistically significant prolongation of F-wave mean latency on peroneal and tibial nerves (p<0.0001, paired t-test). ...
Neurophysiological examination of lower-limb peripheral nerves demonstrated statistically significant prolongation of F-wave mean latency on …
Use of cystatin C determination in clinical diagnostics.
Mares J, Stejskal D, Vavrousková J, Urbánek K, Herzig R, Hlustík P. Mares J, et al. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2003 Dec;147(2):177-80. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2003. PMID: 15037900 Review.
Treatment with statins and involvement of the peripheral nervous system: results of a prospective clinical and neurophysiological follow-up.
Otruba P, Kanovsky P, Hlustik P. Otruba P, et al. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2007 Dec;151(2):307-10. doi: 10.5507/bp.2007.052. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2007. PMID: 18345269
Nevertheless, electrophysiological examination of lower-limb peripheral nerves demonstrated statistically significant prolongation of F-wave mean latency on peroneal and tibial nerves (p < 0.0001, paired t-test). ...
Nevertheless, electrophysiological examination of lower-limb peripheral nerves demonstrated statistically significant prolongation of F-wave …
The assessment of beta amyloid, tau protein and cystatin C in the cerebrospinal fluid: laboratory markers of neurodegenerative diseases.
Mares J, Kanovsky P, Herzig R, Stejskal D, Vavrouskova J, Hlustik P, Vranova H, Burval S, Zapletalova J, Pidrman V, Obereigneru R, Suchy A, Vesely J, Podivinsky J, Urbanek K. Mares J, et al. Neurol Sci. 2009 Feb;30(1):1-7. doi: 10.1007/s10072-008-0005-7. Epub 2009 Jan 20. Neurol Sci. 2009. PMID: 19153649 Clinical Trial.
Statistically significant increased tau protein levels (P = 0.0001) and index tau/beta-amyloid(1-42) levels (P = 0.0002) were shown in the group of AD patients, compared to the group of ND patients. ...
Statistically significant increased tau protein levels (P = 0.0001) and index tau/beta-amyloid(1-42) levels (P = 0.0002) were …
Modulation of cortical activity in patients suffering from upper arm spasticity following stroke and treated with botulinum toxin A: an fMRI study.
Senkárová Z, Hlustík P, Otruba P, Herzig R, Kanovský P. Senkárová Z, et al. J Neuroimaging. 2010 Jan;20(1):9-15. doi: 10.1111/j.1552-6569.2009.00375.x. Epub 2009 May 19. J Neuroimaging. 2010. PMID: 19453837
New laboratory markers in diagnosis of alzheimer dementia.
Mares J, Kanovsky P, Herzig R, Stejskal D, Vavrouskova J, Hlustik P, Vranova H, Burval S, Zapletalova J, Pidrman V, Obereigneru R, Suchy A, Vesely J, Podivinsky J, Urbanek K. Mares J, et al. Neurol Res. 2009 Dec;31(10):1056-9. doi: 10.1179/174313209X385536. Epub 2009 Jul 8. Neurol Res. 2009. PMID: 19589198
Effect of entacapone on plasma homocysteine levels in Parkinson's disease patients.
Nevrly M, Kanovsky P, Vranova H, Langova K, Hlustik P. Nevrly M, et al. Neurol Sci. 2010 Oct;31(5):565-9. doi: 10.1007/s10072-010-0262-0. Epub 2010 May 13. Neurol Sci. 2010. PMID: 20464572
CSF markers of neurodegeneration in Parkinson's disease.
Přikrylová Vranová H, Mareš J, Nevrlý M, Stejskal D, Zapletalová J, Hluštík P, Kaňovský P. Přikrylová Vranová H, et al. J Neural Transm (Vienna). 2010 Oct;117(10):1177-81. doi: 10.1007/s00702-010-0462-z. Epub 2010 Aug 21. J Neural Transm (Vienna). 2010. PMID: 20730548
The following statistically significant differences in the CSF were found: higher tau protein (p = 0.045) and clusterin levels (p = 0.004) in PD patients versus CG; higher tau protein levels (p = 0.033), tau protein/beta-amyloid (1-42) ratio (p = 0.011 …
The following statistically significant differences in the CSF were found: higher tau protein (p = 0.045) and clusterin levels (p
Drug-induced systemic lupus erythematosus in interferon beta-1b therapy.
Sladkova V, Mares J, Lubenova B, Hlustik P, Kanovsky P. Sladkova V, et al. Neuro Endocrinol Lett. 2011;32(1):4-6. Neuro Endocrinol Lett. 2011. PMID: 21407162
83 results
Jump to page
Feedback